| Bacillus cereus |
Bacillus cereus |
MIC |
50.0 |
ug.mL-1 |
10.1021/jm9603779 |
| Bos taurus |
cAMP-dependent protein kinase alpha-catalytic subunit |
IC50 |
10000.0 |
nM |
10.1016/S0960-894X(01)80995-1 |
| Bos taurus |
cGMP-dependent protein kinase 1 alpha |
IC50 |
650.0 |
nM |
10.1016/S0960-894X(01)80995-1 |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Change in IC50 |
8.0 |
fold |
10.1021/jm020427b |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Change in IC50 |
50.0 |
fold |
10.1021/jm020427b |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
IC50 |
8000.0 |
nM |
10.1021/jm030266r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
17.0 |
% |
10.1021/jm030266r |
| Escherichia coli K-12 |
Beta-lactamase AmpC |
Inhibition |
80.0 |
% |
10.1021/jm030266r |
| Gallus gallus |
Myosin light chain kinase, smooth muscle |
IC50 |
2800.0 |
nM |
10.1016/S0960-894X(01)80995-1 |
| Homo sapiens |
78 kDa glucose-regulated protein |
Potency |
14125.4 |
nM |
None |
| Homo sapiens |
Beta-chymotrypsin |
IC50 |
10000.0 |
nM |
10.1021/jm020427b |
| Homo sapiens |
CaM kinase II |
IC50 |
184.0 |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
cAMP-dependent protein kinase (PKA) |
IC50 |
2000.0 |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
cAMP-dependent protein kinase (PKA) |
IC50 |
25700.0 |
nM |
10.1016/S0960-894X(00)80167-5 |
| Homo sapiens |
cAMP-dependent protein kinase (PKA) |
IC50 |
25700.0 |
nM |
10.1021/jm020427b |
| Homo sapiens |
Casein kinase II |
Inhibition |
67.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
c-Jun N-terminal kinase 1 |
Inhibition |
82.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Cyclin-dependent kinase 1/cyclin B |
IC50 |
nan |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
Cyclin-dependent kinase 2/cyclin E |
IC50 |
1000.0 |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
Cyclin-dependent kinase 2/cyclin E |
IC50 |
1000.0 |
nM |
10.1016/s0960-894x(03)00792-3 |
| Homo sapiens |
Cyclin-dependent kinase 4/cyclin D1 |
IC50 |
830.0 |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
Cyclin-dependent kinase 4/cyclin D1 |
IC50 |
830.0 |
nM |
10.1016/s0960-894x(03)00792-3 |
| Homo sapiens |
DNA topoisomerase I |
MIC |
10.0 |
ug.mL-1 |
10.1021/jm9603779 |
| Homo sapiens |
DNA topoisomerase II beta |
MIC |
10.0 |
ug.mL-1 |
10.1021/jm9603779 |
| Homo sapiens |
Eyes absent homolog 2 |
Potency |
1901.5 |
nM |
None |
| Homo sapiens |
Glycogen synthase kinase-3 beta |
Inhibition |
84.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
HCT-116 |
IC50 |
1720.0 |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
HCT-116 |
IC50 |
1720.0 |
nM |
10.1016/s0960-894x(03)00792-3 |
| Homo sapiens |
HepG2 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
Jurkat |
IC50 |
nan |
None |
10.1016/j.bmcl.2009.04.039 |
| Homo sapiens |
K562 |
IC50 |
7800.0 |
nM |
10.1016/j.bmc.2016.05.032 |
| Homo sapiens |
MAP kinase-activated protein kinase 2 |
Inhibition |
83.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
MAP kinase-activated protein kinase 5 |
Inhibition |
50.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
MAP kinase ERK2 |
Inhibition |
37.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
MAP kinase p38 alpha |
Inhibition |
100.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
MAP kinase p38 beta |
Inhibition |
88.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
MAP kinase p38 delta |
Inhibition |
93.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
MAP kinase p38 gamma |
Inhibition |
64.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 11 |
IC50 |
49.0 |
nM |
10.1021/jm051074u |
| Homo sapiens |
Mitogen-activated protein kinase kinase kinase 9 |
IC50 |
138.0 |
nM |
10.1021/jm051074u |
| Homo sapiens |
Mothers against decapentaplegic homolog 3 |
Potency |
12589.3 |
nM |
None |
| Homo sapiens |
NCI-H460 |
IC50 |
3200.0 |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
NCI-H460 |
IC50 |
3200.0 |
nM |
10.1016/s0960-894x(03)00792-3 |
| Homo sapiens |
Nuclear factor erythroid 2-related factor 2 |
Potency |
29092.9 |
nM |
None |
| Homo sapiens |
PANC-1 |
Selectivity Index |
3.0 |
None |
10.1021/jm801420y |
| Homo sapiens |
Protein kinase C alpha |
IC50 |
2450.0 |
nM |
10.1021/jm9603779 |
| Homo sapiens |
Protein kinase C alpha |
Inhibition |
60.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Protein kinase C (PKC) |
IC50 |
2450.0 |
nM |
10.1016/S0960-894X(00)80167-5 |
| Homo sapiens |
Protein kinase C (PKC) |
IC50 |
2450.0 |
nM |
10.1021/acs.jmedchem.7b01231 |
| Homo sapiens |
Protein kinase C (PKC) |
IC50 |
2450.0 |
nM |
10.1021/jm020427b |
| Homo sapiens |
Protein kinase C (PKC) |
IC50 |
nan |
nM |
10.1016/s0960-894x(03)00791-1 |
| Homo sapiens |
Protein kinase C theta |
IC50 |
2500.0 |
nM |
10.1021/acs.jmedchem.0c01271 |
| Homo sapiens |
Protein kinase C theta |
Inhibition |
50.0 |
% |
10.1021/acs.jmedchem.0c01271 |
| Homo sapiens |
Pyruvate dehydrogenase kinase isoform 1 |
Inhibition |
6.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Ribosomal protein S6 kinase 1 |
Inhibition |
49.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Ribosomal protein S6 kinase alpha 5 |
Inhibition |
62.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Serine/threonine-protein kinase AKT |
Inhibition |
65.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Serine/threonine-protein kinase Chk1 |
Inhibition |
4.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Serine/threonine-protein kinase Sgk1 |
Inhibition |
28.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Tyrosine-protein kinase JAK3 |
IC50 |
61.0 |
nM |
10.1016/j.bmcl.2009.04.039 |
| Homo sapiens |
Tyrosine-protein kinase LCK |
Inhibition |
68.0 |
% |
10.1042/0264-6021:3510095 |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
2818.4 |
nM |
None |
| Homo sapiens |
Tyrosyl-DNA phosphodiesterase 1 |
Potency |
3162.3 |
nM |
None |
| Homo sapiens |
Zinc finger protein GLI1 |
IC50 |
1800.0 |
nM |
10.1021/jm801420y |
| Homo sapiens |
Zinc finger protein GLI2 |
IC50 |
2700.0 |
nM |
10.1021/jm801420y |
| Mus musculus |
B16 |
IC50 |
4800.0 |
nM |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
Mean survival in days |
11.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
Mean survival in days |
11.5 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
Mean survival in days |
23.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
Mean survival in days |
26.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
Mean survival in days |
30.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
T/C x100 |
94.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
T/C x100 |
100.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
T/C x100 |
104.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
T/C x100 |
106.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
Mus musculus |
T/C x100 |
122.0 |
None |
10.1021/jm9603779 |
| Mus musculus |
P388 |
IC50 |
4000.0 |
nM |
10.1021/jm9603779 |
| Mus musculus |
Splenocyte |
IC50 |
nan |
nM |
10.1016/S0960-894X(01)80995-1 |
| Mus musculus |
Transcription factor HES-1 |
Inhibition |
nan |
% |
10.1016/j.bmcl.2009.07.146 |
| Rattus norvegicus |
Choline acetylase |
Control |
162.0 |
% |
10.1016/0960-894X(95)00188-Y |
| Rattus norvegicus |
Protein kinase C (PKC) |
IC50 |
680.0 |
nM |
10.1016/S0960-894X(01)80995-1 |
| Rattus norvegicus |
Rho-associated protein kinase 2 |
Inhibition |
19.0 |
% |
10.1042/0264-6021:3510095 |
| Thermus thermophilus |
Malate dehydrogenase |
IC50 |
8000.0 |
nM |
10.1021/jm020427b |
| None |
NON-PROTEIN TARGET |
IC50 |
1720.0 |
nM |
10.1016/j.bmc.2016.05.032 |
| None |
Unchecked |
IC50 |
8000.0 |
nM |
10.1021/acs.jmedchem.7b01231 |
| None |
Unchecked |
IC50 |
8000.0 |
nM |
10.1021/jm020427b |
| None |
Unchecked |
IC50 |
25700.0 |
nM |
10.1021/acs.jmedchem.7b01231 |
| None |
Unchecked |
IC50 |
25700.0 |
nM |
10.1021/jm9603779 |
| None |
Unchecked |
Inhibition |
0.0 |
% |
10.1042/0264-6021:3510095 |
| None |
Unchecked |
Inhibition |
29.0 |
% |
10.1042/0264-6021:3510095 |
| None |
Unchecked |
Inhibition |
30.0 |
% |
10.1042/0264-6021:3510095 |
| None |
Unchecked |
Inhibition |
59.0 |
% |
10.1042/0264-6021:3510095 |
| None |
Unchecked |
Inhibition |
99.0 |
% |
10.1042/0264-6021:3510095 |
| None |
Unchecked |
Potency |
2685.9 |
nM |
None |
| None |
Unchecked |
Potency |
3548.1 |
nM |
None |
| None |
Unchecked |
Potency |
3981.1 |
nM |
None |